These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30223294)

  • 1. Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.
    Stevelink R; Koeleman BPC; Sander JW; Jansen FE; Braun KPJ
    Eur J Neurol; 2019 Jun; 26(6):856-864. PubMed ID: 30223294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME).
    Fayad C; Saad K; Kahwagi GJ; Hallit S; Griffin D; Abou-Khalil R; El-Hayek E
    PLoS One; 2024; 19(4):e0300930. PubMed ID: 38593118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse after treatment withdrawal of antiepileptic drugs for Juvenile Absence Epilepsy and Juvenile Myoclonic Epilepsy.
    Healy L; Moran M; Singhal S; O'Donoghue MF; Alzoubidi R; Whitehouse WP
    Seizure; 2018 Jul; 59():116-122. PubMed ID: 29807291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center.
    Cação G; Parra J; Mannan S; Sisodiya SM; Sander JW
    Epilepsy Behav; 2018 May; 82():81-86. PubMed ID: 29602081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years.
    Syvertsen MR; Thuve S; Stordrange BS; Brodtkorb E
    Seizure; 2014 May; 23(5):344-8. PubMed ID: 24512779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis.
    Stevelink R; Al-Toma D; Jansen FE; Lamberink HJ; Asadi-Pooya AA; Farazdaghi M; Cação G; Jayalakshmi S; Patil A; Özkara Ç; Aydın Ş; Gesche J; Beier CP; Stephen LJ; Brodie MJ; Unnithan G; Radhakrishnan A; Höfler J; Trinka E; Krause R; ; Irelli EC; Di Bonaventura C; Szaflarski JP; Hernández-Vanegas LE; Moya-Alfaro ML; Zhang Y; Zhou D; Pietrafusa N; Specchio N; Japaridze G; Beniczky S; Janmohamed M; Kwan P; Syvertsen M; Selmer KK; Vorderwülbecke BJ; Holtkamp M; Viswanathan LG; Sinha S; Baykan B; Altindag E; von Podewils F; Schulz J; Seneviratne U; Viloria-Alebesque A; Karakis I; D'Souza WJ; Sander JW; Koeleman BPC; Otte WM; Braun KPJ
    EClinicalMedicine; 2022 Nov; 53():101732. PubMed ID: 36467455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizure outcome in 175 patients with juvenile myoclonic epilepsy--a long-term observational study.
    Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
    Epilepsy Res; 2014 Dec; 108(10):1817-24. PubMed ID: 25443450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.
    Geithner J; Schneider F; Wang Z; Berneiser J; Herzer R; Kessler C; Runge U
    Epilepsia; 2012 Aug; 53(8):1379-86. PubMed ID: 22686598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors.
    Senf P; Schmitz B; Holtkamp M; Janz D
    Neurology; 2013 Dec; 81(24):2128-33. PubMed ID: 24212391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types.
    Kitazawa Y; Jin K; Kakisaka Y; Fujikawa M; Tanaka F; Nakasato N
    Epilepsy Res; 2018 Aug; 144():20-24. PubMed ID: 29729533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotyping juvenile myoclonic epilepsy. Praxis induction as a biomarker of unfavorable prognosis.
    Uchida CG; de Carvalho KC; Guaranha MS; Guilhoto LM; de Araújo Filho GM; Wolf P; Yacubian EM
    Seizure; 2015 Nov; 32():62-8. PubMed ID: 26552565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A; Brodie MJ
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drug withdrawal in juvenile myoclonic epilepsy.
    Syvertsen M; Fløgstad I; Enger U; Landmark CJ; Koht J
    Acta Neurol Scand; 2019 Feb; 139(2):192-198. PubMed ID: 30378684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-specific disease modifiers in juvenile myoclonic epilepsy.
    Shakeshaft A; Panjwani N; Collingwood A; Crudgington H; Hall A; Andrade DM; Beier CP; Fong CY; Gardella E; Gesche J; Greenberg DA; Hamandi K; Koht J; Lim KS; Møller RS; Ng CC; Orsini A; Rees MI; Rubboli G; Selmer KK; Striano P; Syvertsen M; Thomas RH; Zarubova J; Richardson MP; Strug LJ; Pal DK
    Sci Rep; 2022 Feb; 12(1):2785. PubMed ID: 35190554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic analysis of juvenile myoclonic epilepsy in Indian families.
    Jain S; Tripathi M; Srivastava AK; Narula A
    Acta Neurol Scand; 2003 May; 107(5):356-62. PubMed ID: 12713528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of juvenile myoclonic epilepsy in people <30 years of age-A population-based study in Norway.
    Syvertsen M; Hellum MK; Hansen G; Edland A; Nakken KO; Selmer KK; Koht J
    Epilepsia; 2017 Jan; 58(1):105-112. PubMed ID: 27861775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
    Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI
    Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate monotherapy for juvenile myoclonic epilepsy.
    Liu J; Wang LN; Wang YP
    Cochrane Database Syst Rev; 2015 Dec; (12):CD010008. PubMed ID: 26695884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoclonic status epilepticus in juvenile myoclonic epilepsy.
    Larch J; Unterberger I; Bauer G; Reichsoellner J; Kuchukhidze G; Trinka E
    Epileptic Disord; 2009 Dec; 11(4):309-14. PubMed ID: 20045780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile myoclonic epilepsy: Long-term prognosis and risk factors.
    Pietrafusa N; La Neve A; de Palma L; Boero G; Luisi C; Vigevano F; Specchio N
    Brain Dev; 2021 Jun; 43(6):688-697. PubMed ID: 33781581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.